Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness

Greet Van Den Berghe, Pieter Wouters, Cyril Y. Bowers, Francis De Zegher, Roger Bouillon, Johannes D Veldhuis

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Objective: During prolonged critical illness, nocturnal pulsatile secretion of GH, TSH and prolactin (PRL) is uniformly reduced but remains responsive to the continuous infusion of GH secretagogues and TRH. Whether such (pertinent) secretagogues would synchronize pituitary secretion of GH, TSH and/or PRL is not known. Design and methods: We explored temporal coupling among GH, TSH and PRL release by calculating cross-correlation among GH, TSH and PRL serum concentration profiles in 86 time series obtained from prolonged critically ill patients by nocturnal blood sampling every 20 min for 9 h during 21-h infusions of either placebo (n = 22), GHRH (1 μg/kg/h; n = 10), GH-releasing peptide-2 (GHRP-2; 1 μg/kg/h; n = 28), TRH (1 μg/kg/h; n = 8) or combinations of these agonists (n = 18). Results: The normal synchrony among GH, TSH and PRL was absent during placebo delivery. Infusion of GHRP-2, but not GHRH or TRH, markedly synchronized serum profiles of GH, TSH and PRL (all P≤0.007). After addition of GHRH and TRH to the infusion of GHRP-2, only the synchrony between GH and PRL was maintained (P=0.003 for GHRH+GHRP-2 and P=0.006 for TRH + GHRH + GHRP-2), and was more marked than with GHRP-2 infusion alone (P = 0.0006 by ANOVA). Conclusions: The nocturnal GH, TSH and PRL secretory patterns during prolonged critical illness are herewith further characterized to include loss of synchrony among GH, TSH and PRL release. The synchronizing effect of an exogenous GHRP-2 drive, but not of GHRH or TRH, suggests that the presumed endogenous GHRP-like ligand may participate in the orchestration of coordinated anterior pituitary hormone release.

Original languageEnglish (US)
Pages (from-to)17-22
Number of pages6
JournalEuropean Journal of Endocrinology
Volume140
Issue number1
DOIs
StatePublished - Jan 1999
Externally publishedYes

Fingerprint

Thyrotropin
Critical Illness
Prolactin
Growth Hormone
Placebos
Anterior Pituitary Hormones
growth hormone-releasing peptide-2
Serum
Analysis of Variance
Ligands
Peptides

ASJC Scopus subject areas

  • Endocrinology

Cite this

Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness. / Van Den Berghe, Greet; Wouters, Pieter; Bowers, Cyril Y.; De Zegher, Francis; Bouillon, Roger; Veldhuis, Johannes D.

In: European Journal of Endocrinology, Vol. 140, No. 1, 01.1999, p. 17-22.

Research output: Contribution to journalArticle

Van Den Berghe, Greet ; Wouters, Pieter ; Bowers, Cyril Y. ; De Zegher, Francis ; Bouillon, Roger ; Veldhuis, Johannes D. / Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness. In: European Journal of Endocrinology. 1999 ; Vol. 140, No. 1. pp. 17-22.
@article{9aa5fe2530054c45a9e554006e70386e,
title = "Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness",
abstract = "Objective: During prolonged critical illness, nocturnal pulsatile secretion of GH, TSH and prolactin (PRL) is uniformly reduced but remains responsive to the continuous infusion of GH secretagogues and TRH. Whether such (pertinent) secretagogues would synchronize pituitary secretion of GH, TSH and/or PRL is not known. Design and methods: We explored temporal coupling among GH, TSH and PRL release by calculating cross-correlation among GH, TSH and PRL serum concentration profiles in 86 time series obtained from prolonged critically ill patients by nocturnal blood sampling every 20 min for 9 h during 21-h infusions of either placebo (n = 22), GHRH (1 μg/kg/h; n = 10), GH-releasing peptide-2 (GHRP-2; 1 μg/kg/h; n = 28), TRH (1 μg/kg/h; n = 8) or combinations of these agonists (n = 18). Results: The normal synchrony among GH, TSH and PRL was absent during placebo delivery. Infusion of GHRP-2, but not GHRH or TRH, markedly synchronized serum profiles of GH, TSH and PRL (all P≤0.007). After addition of GHRH and TRH to the infusion of GHRP-2, only the synchrony between GH and PRL was maintained (P=0.003 for GHRH+GHRP-2 and P=0.006 for TRH + GHRH + GHRP-2), and was more marked than with GHRP-2 infusion alone (P = 0.0006 by ANOVA). Conclusions: The nocturnal GH, TSH and PRL secretory patterns during prolonged critical illness are herewith further characterized to include loss of synchrony among GH, TSH and PRL release. The synchronizing effect of an exogenous GHRP-2 drive, but not of GHRH or TRH, suggests that the presumed endogenous GHRP-like ligand may participate in the orchestration of coordinated anterior pituitary hormone release.",
author = "{Van Den Berghe}, Greet and Pieter Wouters and Bowers, {Cyril Y.} and {De Zegher}, Francis and Roger Bouillon and Veldhuis, {Johannes D}",
year = "1999",
month = "1",
doi = "10.1530/eje.0.1400017",
language = "English (US)",
volume = "140",
pages = "17--22",
journal = "European Journal of Endocrinology",
issn = "0804-4643",
publisher = "BioScientifica Ltd.",
number = "1",

}

TY - JOUR

T1 - Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness

AU - Van Den Berghe, Greet

AU - Wouters, Pieter

AU - Bowers, Cyril Y.

AU - De Zegher, Francis

AU - Bouillon, Roger

AU - Veldhuis, Johannes D

PY - 1999/1

Y1 - 1999/1

N2 - Objective: During prolonged critical illness, nocturnal pulsatile secretion of GH, TSH and prolactin (PRL) is uniformly reduced but remains responsive to the continuous infusion of GH secretagogues and TRH. Whether such (pertinent) secretagogues would synchronize pituitary secretion of GH, TSH and/or PRL is not known. Design and methods: We explored temporal coupling among GH, TSH and PRL release by calculating cross-correlation among GH, TSH and PRL serum concentration profiles in 86 time series obtained from prolonged critically ill patients by nocturnal blood sampling every 20 min for 9 h during 21-h infusions of either placebo (n = 22), GHRH (1 μg/kg/h; n = 10), GH-releasing peptide-2 (GHRP-2; 1 μg/kg/h; n = 28), TRH (1 μg/kg/h; n = 8) or combinations of these agonists (n = 18). Results: The normal synchrony among GH, TSH and PRL was absent during placebo delivery. Infusion of GHRP-2, but not GHRH or TRH, markedly synchronized serum profiles of GH, TSH and PRL (all P≤0.007). After addition of GHRH and TRH to the infusion of GHRP-2, only the synchrony between GH and PRL was maintained (P=0.003 for GHRH+GHRP-2 and P=0.006 for TRH + GHRH + GHRP-2), and was more marked than with GHRP-2 infusion alone (P = 0.0006 by ANOVA). Conclusions: The nocturnal GH, TSH and PRL secretory patterns during prolonged critical illness are herewith further characterized to include loss of synchrony among GH, TSH and PRL release. The synchronizing effect of an exogenous GHRP-2 drive, but not of GHRH or TRH, suggests that the presumed endogenous GHRP-like ligand may participate in the orchestration of coordinated anterior pituitary hormone release.

AB - Objective: During prolonged critical illness, nocturnal pulsatile secretion of GH, TSH and prolactin (PRL) is uniformly reduced but remains responsive to the continuous infusion of GH secretagogues and TRH. Whether such (pertinent) secretagogues would synchronize pituitary secretion of GH, TSH and/or PRL is not known. Design and methods: We explored temporal coupling among GH, TSH and PRL release by calculating cross-correlation among GH, TSH and PRL serum concentration profiles in 86 time series obtained from prolonged critically ill patients by nocturnal blood sampling every 20 min for 9 h during 21-h infusions of either placebo (n = 22), GHRH (1 μg/kg/h; n = 10), GH-releasing peptide-2 (GHRP-2; 1 μg/kg/h; n = 28), TRH (1 μg/kg/h; n = 8) or combinations of these agonists (n = 18). Results: The normal synchrony among GH, TSH and PRL was absent during placebo delivery. Infusion of GHRP-2, but not GHRH or TRH, markedly synchronized serum profiles of GH, TSH and PRL (all P≤0.007). After addition of GHRH and TRH to the infusion of GHRP-2, only the synchrony between GH and PRL was maintained (P=0.003 for GHRH+GHRP-2 and P=0.006 for TRH + GHRH + GHRP-2), and was more marked than with GHRP-2 infusion alone (P = 0.0006 by ANOVA). Conclusions: The nocturnal GH, TSH and PRL secretory patterns during prolonged critical illness are herewith further characterized to include loss of synchrony among GH, TSH and PRL release. The synchronizing effect of an exogenous GHRP-2 drive, but not of GHRH or TRH, suggests that the presumed endogenous GHRP-like ligand may participate in the orchestration of coordinated anterior pituitary hormone release.

UR - http://www.scopus.com/inward/record.url?scp=0033051329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033051329&partnerID=8YFLogxK

U2 - 10.1530/eje.0.1400017

DO - 10.1530/eje.0.1400017

M3 - Article

VL - 140

SP - 17

EP - 22

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

SN - 0804-4643

IS - 1

ER -